Thompson Cancer Survival Ctr Foundation
Programs
Program 1 [2020]
Multidisciplinary Operating Grant: The Foundation provides grant support for the operations of the Multidisciplinary Treatment Department of the Thompson Cancer Survival Center. Multidisciplinary treatment allows specialty physicians to discuss treatment options based on each patient's circumstances. A multidisciplinary nurse navigator schedules a private consultation for each patient with the members of the specialty team. This approach gives the physician the opportunity to relate one-on-one with the oncology patient and explain treatment choices in layman's terms. Patients in need of this support come from various Covenant Health facilities, as well as outside facilities or other healthcare providers.Thompson's Nurse Navigators assist oncology patients according to their needs and help them overcome multiple barriers to healthcare. Common barriers include financial, educational, transportation, logistical, linguistic, cultural, and emotional factors, as well as the complicated health care system in general. The Nurse Navigators guide patients to sources of financial support, help complete paperwork, educate patients on diagnoses and medical procedures, arrange and coordinate appointments with multiple providers, help with transportation, assist with housing, communicate with providers about unique patient needs, ensure medical records arrive at scheduled appointments, direct patients to support groups or counseling services, and attend patient appointments for support.In 2020, there were 21,985 oncology patient education encounters and 1,328 patients assisted by Nurse Navigators. There were 1,014 patients presented at multidisciplinary conferences where a Nurse Navigator attends with the patient to educate, offer support, and serve as a liason for patients and families for all services. For those patients being followed by navigators that have curative treatment, over 160 Survivorship Care Plans were completed by Nurse Navigators and discussed with patients in 2020. Two new Nurse Navigators were added to the program in 2020.Nurse Navigators also led the Low Dose CT Lung Screening Program for Fort Sanders Regional and Fort Sanders West. There were 573 total patients scheduled for screenings in 2020. Twenty-three patients were found to have an abnormal result. All Low Dose CT patients are followed by the multidisciplinary department.GeographiesNot indicatedDatesJan 1, 2020 – Dec 31, 2020Source990No causes providedNo populations provided–$963.8KProgram 2 [2020]
Social Services Operating Grant:The Foundation provides grant support for the operations of the Social Services Department of the Thompson Cancer Survival Center. The Social Services Department receives referrals from Covenant Health facilities when oncology patients are identified that could benefit from the services provided by this department. In 2020, Social Services supported 1,701 new patient referrals and 4,290 follow-up patients. Additionally, there were 617 new patients referred for nutritional counseling and education and 1,420 follow-up patients. The Social Services Department also offers genetic counseling services including breast cancer and hereditary cancer risk assessments. In 2020, the Genetics Clinic provided services for 523 new patients who were in need of counseling, including 313 who pursued genetic testing. Whether patients tested positive or negative for a hereditary cancer syndrome, decided not to pursue testing, or were not appropriate candidates for testing, they and their families were able to make informed decisions regarding their medical management based on the genetic counseling they received. All patients received education, counseling and guidelines based on recommendations informed by their personal health history, family health history, and genetic testing results.GeographiesNot indicatedDatesJan 1, 2020 – Dec 31, 2020Source990No causes providedNo populations provided–$516.9KProgram 3 [2020]
Clinical Trials Operating Grant:The Foundation provides a grant to the Thompson Cancer Survival Center for the operation of its Clinical Trials program. Since the opening of TCSC in 1988, the Clinical Trials Department has enrolled 2,688 patients in clinical trials. The TCSC Clinical Trials Department currently has 15 active treatment patients and 170 patients in follow-up studies. In 2020, despite the pandemic, TCSC Clinical Trials Department enrolled 6 patients to oncology clinical trials. In May 2020, TCSC joined the COVID-19 Cancer Consortium and has enrolled 55 patients to date. The oncology research staff opened the convalescent plasma trial through Mayo Clinic in May 2020 and enrolled 250 patients, allowing those patients to receive lifesaving plasma as part of their therapy for COVID-19. To help with screening efforts for potential clinical trial participants, Research Nurse Coordinators are assigned to specific physician schedules and locations, including Thompson Oncology Group's Oak Ridge, Sevierville, West Knoxville, Downtown Knoxville, and Lenoir City locations. Opening new studies increases referrals locally and regionally and gives current patients the ability to be treated with state-of-the-art care in their own community. Involvement in prevention, treatment, and data and specimen collection trials offers an improved means of health strategies for individuals at risk for certain cancers, as well as access to proven standard cancer treatments and new, developing cutting edge therapies for those diagnosed with cancer.GeographiesNot indicatedDatesJan 1, 2020 – Dec 31, 2020Source990No causes providedNo populations provided–$219.2K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)